Author: Katherine Lymn
Source: Katherine Lymn
Interest: The HIV drug Ziagen was a prime example of what commercializing research — called “tech transfer” — can mean for a university. Ziagen, which prevents the HIV virus from reproducing, has made the University and inventor Robert Vince a combined $524 million since 1999.
Link: http://www.mndaily.com/2011/10/06/u-heads-‘patent-cliff’
Loading...